Status:
COMPLETED
Impact of Paramedical Consultations in Oncological Supportive Care in Outpatients With Multiple Myeloma
Lead Sponsor:
Centre Henri Becquerel
Conditions:
Multiple Myeloma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Multiple myeloma is the second most frequent hematologic malignancy, which incidence augmented between 1995 and 2018, with an annual mean variation of +0.6% to 1.1%. Although treatment improved in the...
Eligibility Criteria
Inclusion
- Age superior to 18 years old
- Patient recently diagnosed with multiple myeloma not eligible to autologous blood stem-cell transplantation, before starting therapy in day hospital
- Patient coming regularly to Centre Henri Becquerel for treatment and follow up for multiple myeloma
- Informed consent form signed
Exclusion
- Inclusion Criteria:
- Age superior to 18 years old
- Patient recently diagnosed with multiple myeloma not eligible to autologous blood stem-cell transplantation, before starting therapy in day hospital
- Patient coming regularly to Centre Henri Becquerel for treatment and follow up for multiple myeloma
- Informed consent form signed
Key Trial Info
Start Date :
June 3 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 26 2025
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT05355987
Start Date
June 3 2022
End Date
June 26 2025
Last Update
January 2 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Henri Becquerel
Rouen, France